Phio Pharmaceuticals Files 8-K for Material Agreement
Ticker: PHIO · Form: 8-K · Filed: Apr 8, 2026 · CIK: 0001533040
| Field | Detail |
|---|---|
| Company | Phio Pharmaceuticals Corp. (PHIO) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, 8-k
TL;DR
Phio Pharma just signed a big deal, filing an 8-K to make it official.
AI Summary
Phio Pharmaceuticals Corp. filed an 8-K on April 8, 2026, to report the entry into a material definitive agreement. The filing includes financial statements and exhibits related to this agreement. Specific details of the agreement, including parties involved and financial terms, are not elaborated in the provided text.
Why It Matters
This filing indicates a significant new contract or partnership for Phio Pharmaceuticals, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could carry significant financial or operational implications, but the lack of specific details makes the exact risk level uncertain.
Key Players & Entities
- Phio Pharmaceuticals Corp. (company) — Filer of the 8-K report
- 0001533040 (company) — CIK number for Phio Pharmaceuticals Corp.
- 0001437749-26-011761 (company) — SEC Accession Number for the filing
- April 8, 2026 (date) — Filing Date and Period of Report
FAQ
What type of material definitive agreement did Phio Pharmaceuticals Corp. enter into?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into.
When was the 8-K filing accepted by the SEC?
The 8-K filing was accepted on April 8, 2026, at 16:15:54.
What are the main items reported in this 8-K filing?
The main items reported are Item 1.01 (Entry into a Material Definitive Agreement) and Item 9.01 (Financial Statements and Exhibits).
Where is Phio Pharmaceuticals Corp. located?
Phio Pharmaceuticals Corp. is located at 411 SWEDELAND ROAD SUITE 23-1080 KING OF PRUSSIA PA 19406.
What is the CIK number for Phio Pharmaceuticals Corp.?
The CIK number for Phio Pharmaceuticals Corp. is 0001533040.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2026 regarding Phio Pharmaceuticals Corp. (PHIO).